| __timestamp | AbbVie Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 16758000 |
| Thursday, January 1, 2015 | 6387000000 | 17793000 |
| Friday, January 1, 2016 | 5855000000 | 18761000 |
| Sunday, January 1, 2017 | 6275000000 | 19287000 |
| Monday, January 1, 2018 | 7399000000 | 18707000 |
| Tuesday, January 1, 2019 | 6942000000 | 20893000 |
| Wednesday, January 1, 2020 | 11299000000 | 25678000 |
| Friday, January 1, 2021 | 12349000000 | 29665000 |
| Saturday, January 1, 2022 | 15260000000 | 43628000 |
| Sunday, January 1, 2023 | 12872000000 | 69135000 |
| Monday, January 1, 2024 | 14752000000 |
Unleashing the power of data
In the world of pharmaceuticals, the financial strategies of companies can be as varied as their drug portfolios. AbbVie Inc., a giant in the industry, has consistently demonstrated robust spending on Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, AbbVie's SG&A costs surged by approximately 66%, peaking in 2022. This reflects their aggressive market strategies and expansive operations. In contrast, Geron Corporation, a smaller player, has shown a more modest increase in SG&A expenses, with a notable rise of over 300% from 2014 to 2023. This growth, while significant, highlights Geron's strategic focus on lean operations and targeted investments. The stark contrast between these two companies underscores the diverse approaches within the pharmaceutical sector, where size and strategy dictate financial priorities.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation